These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1819921)

  • 1. Comparative study of the hypotensive effect of a group of structural derivatives of glaucine.
    Todorov S; Zamfirova R
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):98-103. PubMed ID: 1819921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies of a group of semi-synthetic structural analogues of glaucine.
    Petkov V; Todorov S; Georgiev V; Petkova B; Donev N
    Acta Physiol Pharmacol Bulg; 1979; 5(4):3-12. PubMed ID: 543409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.
    Orallo F; Fernández Alzueta A; Campos-Toimil M; Calleja JM
    Br J Pharmacol; 1995 Apr; 114(7):1419-27. PubMed ID: 7606346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glaucine and some glaucine derivatives and of their combination with L-DOPA on the brain level of biogenic monoamines.
    Petkov V; Yanev S; Stancheva S
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):83-92. PubMed ID: 7181577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of glaucine in rodents.
    Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
    Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive effect of aqueous extract of the leaves of Phyllanthus amarus Schum and Thonn (Euphorbiaceae).
    Amaechina FC; Omogbai EK
    Acta Pol Pharm; 2007; 64(6):547-52. PubMed ID: 18323250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective assessment of cough suppressants under normal and pathological experimental conditions.
    Nosál'ová G; Strapková A; Korpás J; Criscuolo D
    Drugs Exp Clin Res; 1989; 15(2):77-81. PubMed ID: 2737083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertensive activity of isoteolin].
    Zheliazkov D; Markov M
    Eksp Med Morfol; 1984; 23(3):127-33. PubMed ID: 6549162
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro inhibition of cyclic 3' 5',-AMP-phosphodiesterase by a group of structural analogues of glaucine.
    Petkov V; Stancheva S
    Acta Physiol Pharmacol Bulg; 1980; 6(3):38-47. PubMed ID: 6269351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on dl-glaucine phosphate as an antitussive.
    Kasé Y; Kawaguchi M; Takahama K; Miyata T; Hirotsu I; Hitoshi T; Okano Y
    Arzneimittelforschung; 1983; 33(7):936-46. PubMed ID: 6354197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally mediated hypotensive effect of E coli endotoxin in the anesthetized cat.
    Koyama S; Santiesteban HL; Ammons WS; Manning JW
    Circ Shock; 1982; 9(6):557-70. PubMed ID: 6758978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to a moderate intensity static magnetic field enhances the hypotensive effect of a calcium channel blocker in spontaneously hypertensive rats.
    Okano H; Ohkubo C
    Bioelectromagnetics; 2005 Dec; 26(8):611-23. PubMed ID: 16189831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U-54,669F: a novel hypotensive agent.
    Wendling MG; DuCharme DW; Johnson GA; McCall RB; Pals DT
    Fed Proc; 1983 Feb; 42(2):162-6. PubMed ID: 6822289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of neuromuscular blocking action of isocorydine methochloride, a new quaternary alkaloid from Cocculus laurifolius DC.
    Mukherjee KC; Patnaik GK; Bhakuni DS; Dhawan BN
    Indian J Exp Biol; 1984 Jan; 22(1):54-6. PubMed ID: 6746025
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nicotine on brain stem mechanisms of cardiovascular control.
    Tseng CJ; Appalsamy M; Robertson D; Mosqueda-Garcia R
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1511-8. PubMed ID: 8099622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quinolozidinylalkylamines with antihypertensive activity].
    Boido V; Boido A; Boido-Canu C; Sparatore F
    Farmaco Sci; 1979 Aug; 34(8):673-87. PubMed ID: 467633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.